PCM
PASG icon

Pinz Capital Management’s Passage Bio PASG Stock Holding History

Pinz Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-540
Closed -$108K – 449
2021
Q3 		$108K Buy
+540
New +$129K 0.05% 112
2020
Q2 		– Sell
-213
Closed -$67K – 178
2020
Q1 		$67K Buy
+213
New +$66.6K 0.18% 46

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinz Capital Management's PASG Position: Q4 2021 in Review

Pinz Capital Management sold out of Passage Bio (PASG) in Q4 2021, closing a stake of 540 shares — an estimated $108K sold.

Pinz Capital Management first reported a position in PASG in Q1 2020 and held it in 2 quarters. The position peaked at $108K in Q3 2021. 99 funds tracked by Wall St. Rank hold PASG as of Q4 2021.

  • Pinz Capital Management reported no remaining Passage Bio position as of Q4 2021 after selling out during the quarter.
  • Pinz Capital Management sold 540 Passage Bio shares in Q4 2021, an estimated $108K.
  • Pinz Capital Management first reported a position in Passage Bio in Q1 2020 and held it in 2 quarters.
  • Pinz Capital Management's Passage Bio position peaked at $108K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Passage Bio as of Q4 2021.

Based on Pinz Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.